Search results
Pfizer expands cost cuts with new $1.5B target
BioPharma Dive via Yahoo Finance· 4 days agoThe company, which previously announced plans to trim $4 billion in spending by the end of 2024, aims to save another $1.5 billion over the next three...
Pfizer (NYSE:PFE) Shares Up 2%
ETF DAILY NEWS· 2 days agoPfizer Inc. (NYSE:PFE – Get Free Report)’s share price was up 2% during trading on Wednesday . The stock traded as high as $29.18 and last traded at $29.13. Approximately ...
Pfizer Wins $107.5M Verdict Against AstraZeneca Over Cancer Drug Patent Dispute
Benzinga· 5 days agoA Delaware federal jury has determined that AstraZeneca Plc AZN must pay Pfizer Inc PFE $107.5...
Pfizer's Hospira Recalls Select Hydrochloride Injection Carpuject Units
RTT News· 3 days agoHospira, Inc., affiliated to dug major Pfizer Inc., is recalling select lots of Buprenorphine Hydrochloride Injection Carpuject Units and Labetalol Hydrochloride Injection ...
Octapharma USA Appoints New VP of Commercial Marketing & Development
New Jersey Business Magazine· 6 days agoOctapharma USA, Inc. has appointed pharmaceutical industry veteran Kelly Hearn as vice president of...
AstraZeneca sets sights on $80B in revenue by 2030
BioPharma Dive via Yahoo Finance· 5 days agoNonetheless, “management's successful track record” in delivering on its promises could give credibility to the company’s goal, Welford added. “[T]he new...
Gene Panel Predicts Early HER2+ Breast Cancer Prognosis
Medscape· 6 days agoPatients with early-stage HER2+ breast cancer could soon be offered less intensive treatment based...
GSK Concealed Risk Associated With Discontinued Heart Burn Drug Zantac, Whistleblower Lawsuit Claims
Benzinga via Yahoo Finance· 4 days agoRelated: Pfizer Agrees To Settle Over 10,000 Lawsuits About Cancer Risks Associated With...
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With Less Than $100 Right Now
Motley Fool via Yahoo Finance· 6 days agoIncreased enforcement of the FDA's flavor ban is great news for Altria. Last year, it acquired NJOY,...
Time to Pounce: 2 Ultra-High-Yield S&P 500 Dividend Stocks That Are Screaming Buys Right Now
Motley Fool via Yahoo Finance· 5 days agoWhereas Pfizer has been a victim of its own success, Walgreens' stock is most definitely flailing...